Are Biologics treating Psoriasis also beneficial against Inflammatory Bowel Disease?

Are Biologics treating Psoriasis also beneficial against Inflammatory Bowel Disease ?

-Il-17 inhibition is the newer class of biologic treatments for psoriasis. They act faster and often achieve complete clearance

-There are three biologics targeting Il-17: Ixekizumab, Secukinumab and Brodalumab
Inflammatory Bowel Disease (Crohn’s (CD) and Ulcerative Colitis (UC)) are more common in psoriasis patients and IL-17 could be involved. (“ 2.5 times more likely to have CD and 1.6 times more likely to have UC”)